19.63M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Diagnostics & Research
Industry

BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada.

Similar securities

Based on sector and market capitalization

Report issue